Frontlight ResearchEarly access
Multiple myeloma trials, also abroad
705 open Multiple myeloma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| United States | 297 |
| China | 204 |
| France | 92 |
| Spain | 81 |
| Italy | 75 |
| All other countries |
The same trial often runs in several countries
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) has 4 sites in South Africa and runs in 29 countries. If a site near you is full, another one may still take people.
See A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) in all 29 countries